In the case of autoimmune diseases caused by uncontrolled expansion of Teff due to TGFβ deficiency, our data suggest that AGXT2 inhibitors may suppress inflammation as our data show T cells are dependent on these two signals to survive in vivo. The gene discussed is AGXT2; the disease is autoimmune disease.